Clinical Trial Update: A Proof-of-concept Study to Evaluate the Efficacy and Safety of Rozanolixizumab to Treat Adult Study Participants With Severe Fibromyalgia Syndrome [Phase 2]

View source ↗

Summary

Phase 2 proof-of-concept trial evaluating Rozanolixizumab for adult patients with severe fibromyalgia; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibromyalgia

Drugs mentioned

• Rozanolixizumab

Snippet

Sponsor: UCB Biopharma SRL | Conditions: Fibromyalgia | Phase 2 | Status: COMPLETED | Results posted: 2025-07-01